These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28223668)

  • 1. [Genetic Counseling of HBOC and Japanese Organization of HBOC].
    Fukushima Y
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):107-110. PubMed ID: 28223668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
    Arai M; Iwase T; Takazawa Y; Takeshima N
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
    Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
    Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
    BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors.
    Berliner JL; Cummings SA; Boldt Burnett B; Ricker CN
    J Genet Couns; 2021 Apr; 30(2):342-360. PubMed ID: 33410258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    Meaney-Delman D; Bellcross CA
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond BRCA1 and BRCA2.
    King-Spohn K; Pilarski R
    Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular Diagnosis and Treatment of HBOC Syndrome].
    Miki Y
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):102-106. PubMed ID: 28223667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
    Arai M; Yokoyama S; Watanabe C; Yoshida R; Kita M; Okawa M; Sakurai A; Sekine M; Yotsumoto J; Nomura H; Akama Y; Inuzuka M; Nomizu T; Enomoto T; Nakamura S
    J Hum Genet; 2018 Apr; 63(4):447-457. PubMed ID: 29176636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].
    Arai M; Taki K; Iwase H; Takizawa K; Nishimura S; Iwase T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):525-31. PubMed ID: 22504676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
    Shao D; Cheng S; Guo F; Zhu C; Yuan Y; Hu K; Wang Z; Meng X; Jin X; Xiong Y; Chai X; Li H; Zhang Y; Zhang H; Liu J; Ye M
    Cancer Sci; 2020 Feb; 111(2):647-657. PubMed ID: 31742824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.
    Yoshida R
    Breast Cancer; 2021 Nov; 28(6):1167-1180. PubMed ID: 32862296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
    Bellcross CA
    Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    Bando H
    Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Genetic Counseling and Testing in an Era of Rapid Change.
    Hooker GW; Clemens KR; Quillin J; Vogel Postula KJ; Summerour P; Nagy R; Buchanan AH
    J Genet Couns; 2017 Dec; 26(6):1244-1253. PubMed ID: 28434142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and Treatment of HBOC Syndrome by a Breast Surgical Oncologist].
    Kida K; Murai M; Yamauchi H
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):111-115. PubMed ID: 28223669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.
    Szender JB; Kaur J; Clayback K; Hutton ML; Mikkelson J; Odunsi K; Dresbold C
    Int J Gynecol Cancer; 2018 Jan; 28(1):26-33. PubMed ID: 28930807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Georgia Primary Care Providers' Knowledge of Hereditary Breast and Ovarian Cancer Syndrome.
    Nair N; Bellcross C; Haddad L; Martin M; Matthews R; Gabram-Mendola S; Crane B; Meaney-Delman D
    J Cancer Educ; 2017 Mar; 32(1):119-124. PubMed ID: 26637472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.